Polar Capital Holdings’s Standard BioTools LAB Stock Holding History

Polar Capital Holdings’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-35,585	Closed	-$68.7K	–	315
2024 Q3	$68.7K	Sell	35,585 -21,000	-37%	-$41.1K	﹤0.01%	288
2024 Q2	$100K	Hold	56,585	–	–	﹤0.01%	271
2024 Q1	$153K	Hold	56,585	–	–	﹤0.01%	277
2023 Q4	$125K	Sell	56,585 -43,415	-43%	-$92.7K	﹤0.01%	273
2023 Q3	$290K	Hold	100,000	–	–	﹤0.01%	271
2023 Q2	$193K	Hold	100,000	–	–	﹤0.01%	284
2023 Q1	$195K	Buy	+100,000	New	+$198K	﹤0.01%	294

Other funds holding LAB

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return

Polar Capital Holdings's LAB Position: Q4 2024 in Review

Polar Capital Holdings sold out of Standard BioTools (LAB) in Q4 2024, closing a stake of 35,585 shares — an estimated $68.7K sold.

Polar Capital Holdings first reported a position in LAB in Q1 2023 and held it in 7 quarters. The position peaked at $290K in Q3 2023. 142 funds tracked by Wall St. Rank hold LAB as of Q4 2024.

Polar Capital Holdings reported no remaining Standard BioTools position as of Q4 2024 after selling out during the quarter.
Polar Capital Holdings sold 35,585 Standard BioTools shares in Q4 2024, an estimated $68.7K.
Polar Capital Holdings first reported a position in Standard BioTools in Q1 2023 and held it in 7 quarters.
Polar Capital Holdings's Standard BioTools position peaked at $290K in Q3 2023.
142 funds tracked by Wall St. Rank held Standard BioTools as of Q4 2024.

Based on Polar Capital Holdings's 13F filing for Q4 2024, filed 14 Feb 2025.